Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with...
Source: prnewswire.com